Bandaram Pharma Packtech Limited (BOM:524602)
India · Delayed Price · Currency is INR 17.98
+0.64 (3.69%)
At close: Aug 21, 2026
Bandaram Pharma Packtech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 7.23 | 1.19 | 0.42 | 1.57 | 20.83 |
Cash & Short-Term Investments | 7.23 | 7.23 | 1.19 | 0.42 | 1.57 | 20.83 |
Cash Growth | 509.19% | 509.19% | 181.71% | -73.17% | -92.47% | 1409417.86% |
Accounts Receivable | - | 313.48 | 187.56 | 145.21 | 66.21 | - |
Other Receivables | - | - | 8.59 | 12.45 | 8.67 | - |
Receivables | - | 313.48 | 196.15 | 179.79 | 74.87 | - |
Inventory | - | 129.43 | 85.05 | 64.68 | 49.7 | - |
Other Current Assets | - | 119.79 | 26.42 | 15.76 | 24.45 | 9.17 |
Total Current Assets | - | 569.93 | 308.81 | 260.64 | 150.59 | 30 |
Property, Plant & Equipment | - | 94.05 | 39.51 | 44.84 | 50.35 | - |
Long-Term Investments | - | - | 14 | 14 | - | - |
Goodwill | - | 58.13 | - | - | - | - |
Long-Term Deferred Tax Assets | - | - | 0.01 | - | - | - |
Long-Term Deferred Charges | - | - | 0.08 | 0.12 | 0.15 | - |
Other Long-Term Assets | - | 36.52 | 26.77 | 0.97 | 0.65 | - |
Total Assets | - | 758.63 | 389.18 | 320.57 | 201.74 | 30 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 162.61 | 43.57 | 41.18 | 2.36 | - |
Accrued Expenses | - | - | 5.65 | 3.15 | 1.85 | 0.1 |
Current Portion of Long-Term Debt | - | 138.94 | 81.64 | 75.26 | 65.55 | - |
Current Income Taxes Payable | - | 5.31 | 3.29 | 2.19 | 0.68 | - |
Other Current Liabilities | - | 36.39 | 6.18 | 0.58 | 3.04 | - |
Total Current Liabilities | - | 343.25 | 140.32 | 122.36 | 73.49 | 0.1 |
Long-Term Debt | - | 100.52 | 89.91 | 46.75 | 76.47 | - |
Long-Term Deferred Tax Liabilities | - | 1.19 | 0.74 | 0.8 | 0.45 | - |
Other Long-Term Liabilities | - | - | - | 0 | -0 | - |
Total Liabilities | - | 444.96 | 230.97 | 169.91 | 150.41 | 0.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 179.72 | 120 | 120 | 30 | 30 |
Retained Earnings | - | 88.1 | 6.52 | 2.8 | 0.83 | -0.1 |
Total Common Equity | 267.81 | 267.81 | 126.52 | 122.8 | 30.83 | 29.9 |
Minority Interest | - | 45.85 | 31.68 | 27.86 | 20.5 | - |
Shareholders' Equity | 313.66 | 313.66 | 158.2 | 150.66 | 51.33 | 29.9 |
Total Liabilities & Equity | - | 758.63 | 389.18 | 320.57 | 201.74 | 30 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 239.46 | 239.46 | 171.55 | 122.02 | 142.03 | - |
Net Cash (Debt) | -232.24 | -232.24 | -170.36 | -121.6 | -140.46 | 20.83 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.64 | -12.96 | -14.20 | -10.13 | -46.82 | 6.94 |
Filing Date Shares Outstanding | 62.22 | 17.32 | 12 | 12 | 3 | 3 |
Total Common Shares Outstanding | 62.22 | 17.32 | 12 | 12 | 3 | 3 |
Working Capital | - | 226.68 | 168.49 | 138.29 | 77.11 | 29.9 |
Book Value Per Share | 15.46 | 15.46 | 10.54 | 10.23 | 10.28 | 9.97 |
Tangible Book Value | 209.69 | 209.69 | 126.52 | 122.8 | 30.83 | 29.9 |
Tangible Book Value Per Share | 12.11 | 12.11 | 10.54 | 10.23 | 10.28 | 9.97 |
Buildings | - | - | 4.2 | 4.2 | - | - |
Machinery | - | - | 55.69 | 54.94 | - | - |